CRMD vs. AU
CRMD (CorMedix Inc.) and AU (AngloGold Ashanti Limited) are both stocks. CRMD operates in Biotechnology (Healthcare), while AU operates in Gold (Basic Materials). Over the past 10 years, CRMD returned -4.90%/yr vs 21.09%/yr for AU. At a 0.05 correlation, their price movements are largely independent.
Performance
CRMD vs. AU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRMD achieves a -29.23% return, which is significantly lower than AU's 8.43% return. Over the past 10 years, CRMD has underperformed AU with an annualized return of -4.90%, while AU has yielded a comparatively higher 21.09% annualized return.
CRMD
- 1D
- 0.73%
- 1M
- 4.18%
- YTD
- -29.23%
- 6M
- -20.25%
- 1Y
- -34.73%
- 3Y*
- 16.99%
- 5Y*
- 2.01%
- 10Y*
- -4.90%
AU
- 1D
- -2.18%
- 1M
- 0.28%
- YTD
- 8.43%
- 6M
- 10.68%
- 1Y
- 104.16%
- 3Y*
- 59.13%
- 5Y*
- 34.87%
- 10Y*
- 21.09%
CRMD vs. AU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | -29.23% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 2.06% | 12.87% | 158.00% | -67.32% |
AU AngloGold Ashanti Limited | 8.43% | 288.18% | 25.43% | -2.68% | -5.09% | -4.87% | 1.90% | 78.89% | 23.96% | -2.23% |
Correlation
The correlation between CRMD and AU is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since May 14, 2010 | 0.05 |
The correlation between CRMD and AU shifts across timeframes, from 0.05 (all time) to 0.21 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
CRMD:
$765.27M
AU:
$45.36B
CRMD:
$2.10
AU:
$6.85
CRMD:
3.92
AU:
13.11
CRMD:
1.77
AU:
4.08
CRMD:
1.75
AU:
5.32
CRMD:
$400.05M
AU:
$11.17B
CRMD:
$343.39M
AU:
$5.82B
CRMD:
$207.97M
AU:
$5.58B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRMD vs. AU — Risk / Return Rank
CRMD
AU
CRMD vs. AU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and AngloGold Ashanti Limited (AU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CRMD | AU | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.51 | 1.84 | -2.34 |
Sortino ratioReturn per unit of downside risk | -0.34 | 2.24 | -2.58 |
Omega ratioGain probability vs. loss probability | 0.95 | 1.29 | -0.34 |
Calmar ratioReturn relative to maximum drawdown | -0.56 | 2.86 | -3.42 |
Martin ratioReturn relative to average drawdown | -0.83 | 8.05 | -8.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CRMD | AU | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.51 | 1.84 | -2.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | 0.72 | -0.69 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.05 | 0.43 | -0.48 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 0.15 | -0.19 |
Drawdowns
CRMD vs. AU - Drawdown Comparison
The maximum CRMD drawdown since its inception was -98.28%, which is greater than AU's maximum drawdown of -90.12%. Use the drawdown chart below to compare losses from any high point for CRMD and AU.
Loading charts...
Drawdown Indicators
| CRMD | AU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -90.12% | -8.16% |
Max Drawdown (1Y)Largest decline over 1 year | -62.26% | -36.59% | -25.67% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -38.86% | -23.40% |
Max Drawdown (5Y)Largest decline over 5 years | -66.91% | -51.75% | -15.16% |
Max Drawdown (10Y)Largest decline over 10 years | -94.77% | -67.91% | -26.86% |
Current DrawdownCurrent decline from peak | -83.32% | -27.90% | -55.42% |
Average DrawdownAverage peak-to-trough decline | -76.98% | -46.09% | -30.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.81% | 12.98% | +28.83% |
Volatility
CRMD vs. AU - Volatility Comparison
The current volatility for CorMedix Inc. (CRMD) is 12.63%, while AngloGold Ashanti Limited (AU) has a volatility of 19.79%. This indicates that CRMD experiences smaller price fluctuations and is considered to be less risky than AU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRMD | AU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.63% | 19.79% | -7.16% |
Volatility (6M)Calculated over the trailing 6-month period | 52.14% | 44.76% | +7.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.84% | 57.08% | +11.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.14% | 48.84% | +28.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.78% | 49.65% | +42.13% |
Dividends
CRMD vs. AU - Dividend Comparison
CRMD has not paid dividends to shareholders, while AU's dividend yield for the trailing twelve months is around 5.12%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
AU AngloGold Ashanti Limited | 5.12% | 2.96% | 1.78% | 1.14% | 2.26% | 2.58% | 0.49% | 0.30% | 0.48% | 0.93% |
CRMD CorMedix Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CRMD vs. AU - Financials Comparison
This section allows you to compare key financial metrics between CorMedix Inc. and AngloGold Ashanti Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRMD vs. AU - Profitability Comparison
CRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.
AU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AngloGold Ashanti Limited reported a gross profit of 1.88B and revenue of 3.24B. Therefore, the gross margin over that period was 58.2%.
CRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.
AU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AngloGold Ashanti Limited reported an operating income of 1.84B and revenue of 3.24B, resulting in an operating margin of 56.8%.
CRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.
AU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AngloGold Ashanti Limited reported a net income of 1.28B and revenue of 3.24B, resulting in a net margin of 39.6%.
Frequently Asked Questions
CRMD and AU have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AU has higher volatility (19.79%) compared to CRMD (12.63%). In terms of maximum drawdown, CRMD dropped -98.28% vs AU's -90.12%.
AU currently has the higher Sharpe Ratio (1.84 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRMD and AU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer